NEW YORK, June 3 (GenomeWeb News) - Harry Stylli, Sequenom's newly hired president and CEO, will receive an annual salary of $420,000 and be eligible for an annual performance bonus of up to 50 percent of that salary.
Already have a GenomeWeb or 360Dx account?Login Now.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.